Specialty Pharmacy

Combination antibody therapy may lead to new melanoma treatment strategy.

Simian immunodeficiency virus may be able to infect human cells.

Specialty pharmacies need to track drug pricing throughout the claims adjudication process to avoid potential liability.

Through a shell company, a New York pharmacist improperly billed Medicaid and others $274 million for illegally obtained HIV drugs.

Nusinersen significantly improved motor milestones and muscle function in spinal muscular atrophy (SMA) during phase 3 trial.

Microfluidic device may lead to new treatments for amyotrophic lateral sclerosis and other neuromuscular-related conditions.

Many conventional tests unable to detect resistance to antiretroviral drugs for HIV.

Mutant KRAS gene may lead to new therapies for lung cancer.

Top news of the day from across the health care landscape.

Pharmacy medication synchronization programs may simplify care for diabetes and other chronic conditions.

New direct-acting antivirals show great efficacy and limited side effects treating hepatitis C.

Targeting early marker of insulin resistance shows promise in type 2 diabetes.

Research sheds light on the mechanism behind the development of spinal muscular atrophy (SMA).

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses how providers can improve patient care through collaboration.

Top news of the day from across the health care landscape.

Monoclonal antibody combination could offer less toxic acute lymphoblastic leukemia treatment.

Outdated measurements of cancer drug response could prevent some patients from receiving beneficial treatments.

Top articles of the week on The American Journal of Pharmacy Benefits.

Top news of the week in oncology, and cancer drug development.

Novel class of antitumor amphiphilic amines causes death in several cancer cell lines.

Creating standard terminology may improve medication safety and efficacy in precision medicine.

Hepatitis B can lead to liver cancer and cirrhosis.

Athletes from a variety of sports dealt with the hardships of diseases treated by specialty pharmacy.

Top news of the day from across the health care landscape.

Access to care improves among post liver transplant patients.

Updated criteria outlined by ASCO may lead to an increase in the number of breast cancers that test HER2-positive.

System would allow for less painful infusions that do not pierce the skin.

Anti-PD-1 antibodies produced more activated antiviral cells to attack HIV.